Vaccine-Preventable Disease

An increased incidence of vaccine-preventable diseases is associated with an increase in proposed bills restricting vaccine exemptions, according to study findings published in JAMA Pediatrics.

Results of an ongoing phase 3 trial of Takeda’s tetravalent dengue vaccine candidate, known as TAK-003, suggest that the vaccine is effective in children and adolescents aged 4 to 16 years.

One of the lessons that health care centers learned during New York City’s recent measles outbreak was to screen patients before they entered the facility — either over the phone or while the patient sat in the car — methods that could help reduce exposure and the spread of disease, according to a report published in Morbidity and Mortality Weekly Report.

The 32nd Annual Infectious Diseases in Children Symposium will take place on Nov. 23 and 24 in New York City.